CELLINI, Luigina
 Distribuzione geografica
Continente #
EU - Europa 6.465
NA - Nord America 5.740
AS - Asia 2.701
Continente sconosciuto - Info sul continente non disponibili 15
AF - Africa 8
SA - Sud America 3
OC - Oceania 2
Totale 14.934
Nazione #
US - Stati Uniti d'America 5.719
IT - Italia 1.464
CN - Cina 1.280
UA - Ucraina 1.126
IE - Irlanda 991
TR - Turchia 834
SE - Svezia 773
FR - Francia 629
GB - Regno Unito 555
DE - Germania 378
IN - India 377
FI - Finlandia 217
SG - Singapore 137
PL - Polonia 125
CZ - Repubblica Ceca 50
RU - Federazione Russa 44
IR - Iran 36
RO - Romania 27
BE - Belgio 26
CA - Canada 18
VN - Vietnam 18
EU - Europa 15
GR - Grecia 12
CH - Svizzera 11
NL - Olanda 10
ES - Italia 7
HK - Hong Kong 6
PT - Portogallo 5
AL - Albania 4
AT - Austria 4
IL - Israele 4
BR - Brasile 3
ET - Etiopia 3
JP - Giappone 3
LY - Libia 3
NO - Norvegia 3
AU - Australia 2
MX - Messico 2
PH - Filippine 2
BG - Bulgaria 1
CR - Costa Rica 1
GE - Georgia 1
KH - Cambogia 1
LT - Lituania 1
LU - Lussemburgo 1
MT - Malta 1
NG - Nigeria 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 14.934
Città #
Jacksonville 1.296
Chandler 1.004
Dublin 944
Princeton 487
Southend 456
Izmir 440
Nanjing 405
Dearborn 381
Chieti 253
Wilmington 245
Beijing 220
Cambridge 220
Ann Arbor 169
Ashburn 156
Woodbridge 131
Nanchang 129
Altamura 122
Kraków 122
New York 102
Singapore 86
Hebei 75
Kunming 70
Boardman 64
Tianjin 60
Shenyang 52
Grevenbroich 50
Rome 42
San Mateo 39
Jiaxing 36
Augusta 32
Brno 32
Pescara 31
Ardabil 30
Milan 30
Changsha 29
Houston 28
Washington 28
Leawood 27
Norwalk 25
Brussels 23
Hangzhou 23
Jinan 23
Kocaeli 23
Lanzhou 23
Vasto 22
Orange 21
Changchun 18
Dong Ket 18
Olomouc 18
Naples 17
Simi Valley 16
Teramo 16
Hefei 15
Torrevecchia Teatina 15
Los Angeles 14
Mumbai 14
Torino 14
Collecorvino 13
Auburn Hills 12
Napoli 12
Redmond 12
Taizhou 12
Helsinki 11
Monmouth Junction 11
Ningbo 11
Shanghai 11
Munich 10
Padova 10
San Vito al Tagliamento 10
Toronto 10
Bologna 9
Seattle 9
Fuzhou 8
Guangzhou 8
Lanciano 8
Palermo 8
Pavia 8
Spoltore 8
Florence 7
Mountain View 7
Ottawa 7
Zhengzhou 7
Bari 6
Düsseldorf 6
Falls Church 6
Foggia 6
Hong Kong 6
Scuola 6
Tappahannock 6
Varallo 6
Verona 6
Catania 5
Edinburgh 5
Haikou 5
Hanover 5
Martinsicuro 5
Montesilvano 5
Turin 5
Andover 4
Bangalore 4
Totale 8.817
Nome #
Differenziamento reale e differenziamento temporaneo 217
Motivi di fosforilazione EPIYA nella patogenesi di Helicobacter pylori 170
Viscoelastic properties of Staphylococcus aureus and Staphylococcus epidermidis mono-microbial biofilms 155
NUOVO TERRENO DI TRASPORTO “GESA” PER L’ISOLAMENTO DI HELICOBACTER PYLORI DA BIOPSIE GASTRICHE 132
Rilievo e ruolo del DNA extracellulare nel biofilm di Helicobacter pylori 128
Antimicrobial and Antibiofilm Efficacy of Graphene Oxide against Chronic Wound Microorganisms 128
Effetto del 2-idrossietil-metacrilato (HEMA) sulla co-coltivazione di Streptococcus Mitis e fibroblastigengivali umani 125
Studio micriobiologico per il rilievo di Helicobacter pylory nel muco nasale di pazienti dispeptici 121
Sintesi e valutazione dell’attività antimicrobica di nuovi carvacrolo codrugs 117
Isolamento di una proteina, mediante cromatografia di affinità con glutatione, da un ceppo anaerobio di Bacteroides fragilis. 109
A Triple and Quadruple Therapy with Doxycycline and Bismuth for First-Line Treatment of Helicobacter pylori Infection: A Pilot Study 104
Liposome-induced exfoliation of graphite to few-layer graphene dispersion with antibacterial activity 103
Transport medium for isolation and identification of Helicobacter pylori. 101
Recupero di Helicobacter pylori ATCC 43504 dallo stato vitale non colturabile (VNC) 100
Trasmissione di Helicobacter pylori in un modello murino 100
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy 99
The viable but not culturable (VBNC) state in helicobacter pylori 97
Helicobacter pylori isolates from proximal and distal stomach of patients never treated and already treated show genetic variability and discordant antibiotic resistance. 96
Adhesion of human gingival fibroblasts/Streptococcus mitis co-culture on the nanocomposite system Chitlac-nAg 96
Confronto di patterns di DNA da Helicobacter pylori isolati dal corpo e dall'antro 93
The effect of O2 deprivation on the morphology and growth of Helicobacter pylori 93
Bovine lactoferrin enhances the efficacy of levofloxacin-based triple therapy as first-line treatment of Helicobacter pylori infection: an in vitro and in vivo study. 93
Arginine- and lysine-rich peptides: Synthesis, characterization and antimicrobial activity 93
Antibacterial effect of plant extracts against Helicobacter pylori 91
Effetto della deprivazione di 02 sulla morfologia e sulla crescita di Helicobacter pylori 90
Treatment of Helicobacter pylori (Hp) infection with an association of Omeprazole and Roxytromicine: a study in vivo and in vitro. 90
Analysis of genetic variability, antimicrobial susceptibility and virulence markers in Helicobacter pylori identified in Central Italy. 89
Synthesis of Short Cationic Antimicrobial Peptidomimetics Containing Arginine Analogs 89
Bacterial response to the exposure of 50 Hz electromagnetic fields. 88
New transport medium for cultural recovery of Helicobacter pylori 88
Questionario di Microbiologia 87
Studio preliminare sull'inattivazione di farmaci antibiotici da parte di una trasferasi prodotta da Providencia stuartii. 87
Pistacia vera L. oleoresin and levofloxacin is a synergistic combination against resistant Helicobacter pylori strains 87
Preliminary studies on the effect of glutathione S-transferase from Providencia stuartii on the antimicrobial activity of different antibiotics. 86
Uso razionale di schemi terapeutici nelle infezioni da Helicobacter pylori 86
Effetti del 2-idrossi-etil-metacrilato sul Biofilm prodotto da Streptococchi orali 86
Biofilm microbici come sistema dinamico in risposta allo stress ambientale. Approcci innovativi nella prevenzione e formulazione di nuove strategie terapeutiche integrate 85
In vitro activity of Aloe vera inner gel against microorganism grown in planktonic and sessile phase 85
Carvacrol codrugs: A new approach in the antimicrobial plan 85
Curcumin, an antibiotic resistance breaker against a multiresistant clinical isolate of Mycobacterium abscessus 84
FUSOBACTERIUM NUCLEATUM (FN) IN PATIENTS AFFECTED BY INFLAMMATORY BOWEL DISEASE 84
Bio-Toxicological Assay to Test Water and Sediment Quality. 83
Adhesive properties of Proteus genus related with antimicrobial agents resistance. 82
null 82
Selezione in vitro delle resistenze a beta-lattamine in recenti stipiti ospedalieri di Enterobacteriaceae e Pseudomonas. 82
Valutazione dell'adesività di ceppi del genere Proteus a cellule dell'epitelio urinario. 82
Attività in vitro di Tea Tree oil e Nerolidol da soli e in combinazione nei confronti di Pediculus capitis e delle sue lendini 82
Anti-H pylori specific antibody immunoistochemistry improves the diagnostic accuracy of H piylori in biopsy specimen from patients treated with triple therapy 81
Purification and characterization of three forms of glutathione transferase from Proteus mirabilis. 81
Activity of tea tree oil and nerolidol alone or in combination against Pediculus capitis (head lice) andits eggs 81
Temporal expression of agrB, cidA and alsS in the early development of Staphylococcus aureus UAMS-1 biofilm formation and the structural role of extracellular DNA and carbohydrates 81
Effects of Extremely Low-Frequency Electromagnetic Fields on Helicobacter pylori Biofilm. 81
Potential Antibacterial Activity of Carvacrol-Loaded PLGA Nanoparticles against Microbial Biofilm 81
Effect of Pefloxacin of Proteus-Providencia spp. to squamous epithelial cells. 80
Enterococcus hirae biofilm formation on hospital material surfaces and effect of new biocides 80
Biological Responses of Human Gingival Fibroblasts (HGFs) in an Innovative Co-Culture Model with Streptococcus mitis to Thermosets Coated with a Silver Polysaccharide Antimicrobial System. 79
Triple therapy for 7 days plus omeprazole for 21 days in treatment of active duodenal ulcer with Helicobacte pylori infection. A double blind placebo controlled trial. 78
Transmission of Helicobacter pylori in an animal model. 78
Candida species isolated from different body sites and their antifungal susceptibility pattern: Cross-analysis of Candida albicans and Candida glabrata biofilms 78
Microbial Contamination of Smartphone Touchscreens of Italian University Students 78
Effects of combining extracts (from Propolis or Zingiber officinale) with Clarithromycin on H.pylori. 77
The effect of oxygen on the growth and cell morphology of Helicobacter pylori. 77
Distribuzione degli isoenzimi della glutatione trasferasi in vari ceppi batterici. 77
Helicobacter pylori in fase planctonica e sessile: comportamento in risposta a diversi terreni di coltura 77
In vitro activity of Aloe vera inner gel against microorganisms grown in planktonic and sessile phases 77
Biofilm formation and modulation of luxS and rpoD expression by Helicobacter pylori. 76
null 76
Detection of Helicobacter pylori in the gastrointestinal tract of Balb/C euthymic mice infected by human Helicobacter pylori and evidence for transmission 75
Virulence factors of Helicobacter pylori. 75
Glutathione transferase in bacteria: subunit composition and antigenic characterization. 74
Dynamic colonization of Helicobacter pylori in human gastric mucosa. 74
Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy.Am. J. Gastroenterol 74
Detection of Helicobacter pylori in saliva and esophagus 74
Extracellular DNA in Helicobacter pylori biofilm: a backstairs rumor 74
Biofilm di Helicobacter pylori: un ambiente naturale per favorire la variabilità genetica 74
Effetto del sistema polisaccaridico di nanoparticelle d’argento (Chitlac-nAg) sui biofilm di Streptococchi orali e saliva 74
Evidence for an oro-fecal transmission inan experimental murine model of helicobacter pylori infection. 73
Role of antimicrobial susceptibility testing on efficacy of triple therapy in Helicobacter pylori eradication. 73
Coccoid Helicobacter pylori not culturable in vitro reverts in mice. 73
Laser irradiation effect on Staphylococcus aureus and Pseudomonas aeruginosa biofilms isolated from venous leg ulcer 73
Cephalosporins are scavengers of hypochlorous acid 73
Liposomes as effective exfoliating agents for graphite 73
Anti-adhesive and pro-apoptotic effects of 2-hydroxyethyl methacrylate on human gingival fibroblasts co-cultured with Streptococcus mitis strains. 73
Detection of Helicobacter pylori associated with zooplankton 72
TWELVE ABERRANT STRAINS OF STAPHYLOCOCCUS AUREUS SUBSP. AUREUS FROM CLINICAL SPECIMENS. 71
Microbiological evidence of Helicobacter pylori from dental plaque in dyspeptic patients. 71
Localization of glutathione transferase B1-1 in Proteus mirabilis 70
Prevalenza della glutatione transferasi nella regione periplasmatica di Proteus mirabilis 70
Streptococcus mitis/human gingival fibroblasts co-culture: the best natural association in answer to the 2-hydroxyethyl methacrylate release. 70
Efficacy of carvacrol against resistant rapidly growing mycobacteria in the planktonic and biofilm growth mode 70
Caratterizzazione e significato clinico della conversione morfologica di helicobacter pylori 68
Recovery of Helicobacter pylori ATCC43504 from a viable but not culturable state: regrowth or resuscitation? 68
Comparative in vitro activities of 13 antimicrobial agents against Morganella-Proteus-Providencia group bacteria from urinary tract infections. 67
Purificazione e caratterizzazione degli isoenzimi della glutatione trasferasi da Proteus mirabilis. 67
Necrosis and/or Apoptosis in Helicobacter pylori 67
Helicobacter pylori strategies to overcome environmental stress 66
Population dynamics in ageing Helicobacter pylori. 66
Analisi della variabilità genetica, della sensibilità antimicrobica e dei fattori di virulenza in ceppi di Helicobacter pylori 66
Characterization of an Helicobacter pylori environmental strain. 66
In vitro synergism of Nalidixic acid with other broad spectrum antibiotics. 65
Totale 8.643
Categoria #
all - tutte 51.602
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.602


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.096 927 218 25 82 272 293 420 314 66 217 246 16
2020/20211.569 237 7 236 21 93 290 25 24 113 226 205 92
2021/20221.180 34 16 39 237 85 22 19 87 120 57 129 335
2022/20233.067 285 402 203 299 268 620 203 218 358 59 92 60
2023/20241.426 82 57 85 54 66 468 340 44 13 28 32 157
2024/202591 91 0 0 0 0 0 0 0 0 0 0 0
Totale 15.417